Evidence map›Paper›PMID 33980714›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Single-cell sequencing reveals suppressive transcriptional programs regulated by MIS/AMH in neonatal ovaries.

Marie-Charlotte Meinsohn, Hatice D Saatcioglu, Lina Wei, Yi Li, Heiko Horn, Maeva Chauvin, Motohiro Kano, Ngoc Minh Phuong Nguyen, Nicholas Nagykery, Aki Kashiwagi and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 85 citations in OpenAlex.

  1. Characterization of Ovarian Cell Types and Molecular Signatures in Mauremys reevesii Using Single-Cell Sequencing.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. AMH protects the ovary from doxorubicin by regulating cell fate and the response to DNA damage.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Marie-Charlotte MeinsohnPediatric Surgical Research Laboratories, Massachusetts General Hospital, Boston, MA 02114.ORCID 0000-0002-1378-4655
Hatice D SaatciogluPediatric Surgical Research Laboratories, Massachusetts General Hospital, Boston, MA 02114.ORCID 0000-0003-2210-0005
Lina WeiPediatric Surgical Research Laboratories, Massachusetts General Hospital, Boston, MA 02114.ORCID 0000-0002-6008-1194
Yi LiPediatric Surgical Research Laboratories, Massachusetts General Hospital, Boston, MA 02114.
Heiko HornPediatric Surgical Research Laboratories, Massachusetts General Hospital, Boston, MA 02114.
Maeva ChauvinPediatric Surgical Research Laboratories, Massachusetts General Hospital, Boston, MA 02114.
Motohiro KanoPediatric Surgical Research Laboratories, Massachusetts General Hospital, Boston, MA 02114.ORCID 0000-0002-5443-0175
Ngoc Minh Phuong NguyenPediatric Surgical Research Laboratories, Massachusetts General Hospital, Boston, MA 02114.
Nicholas NagykeryPediatric Surgical Research Laboratories, Massachusetts General Hospital, Boston, MA 02114.
Aki KashiwagiPediatric Surgical Research Laboratories, Massachusetts General Hospital, Boston, MA 02114.ORCID 0000-0002-2656-8142
Wesley R SamoreDepartment of Pathology, Massachusetts General Hospital, Boston, MA 02114.
Dan WangHorae Gene Therapy Center, University of Massachusetts, Worcester, MA 01605.
Esther OlivaDepartment of Pathology, Massachusetts General Hospital, Boston, MA 02114.
Guangping GaoHorae Gene Therapy Center, University of Massachusetts, Worcester, MA 01605.ORCID 0000-0003-0097-9012
Mary E MorrisDepartment of Gynecology, Massachusetts General Hospital, Boston, MA 02114.ORCID 0000-0002-3508-6305
Patricia K DonahoePediatric Surgical Research Laboratories, Massachusetts General Hospital, Boston, MA 02114; pdonahoe@partners.org dpepin@mgh.harvard.edu.ORCID 0000-0001-5502-4497
David PépinPediatric Surgical Research Laboratories, Massachusetts General Hospital, Boston, MA 02114; pdonahoe@partners.org dpepin@mgh.harvard.edu.ORCID 0000-0003-2046-6708
Harvard University · USUniversity of Massachusetts Chan Medical School · USBroad Institute · US

Funding

Methods of fertility protection by Mullerian inhibiting substance in the female reproductive tract during chemotherapyR01HD102014 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI PEPIN, DAVID · 2020 to 2024
$1.8M
NICHD NIH HHS R01 HD102014
6 · The paper itself

Abstract

Müllerian inhibiting substance (MIS/AMH), produced by granulosa cells of growing follicles, is an important regulator of folliculogenesis and follicle development. Treatment with exogenous MIS in mice suppresses follicle development and prevents ovulation. To investigate the mechanisms by which MIS inhibits follicle development, we performed single-cell RNA sequencing of whole neonatal ovaries treated with MIS at birth and analyzed at postnatal day 6, coinciding with the first wave of follicle growth. We identified distinct transcriptional signatures associated with MIS responses in the ovarian cell types. MIS treatment inhibited proliferation in granulosa, surface epithelial, and stromal cell types of the ovary and elicited a unique signature of quiescence in granulosa cells. In addition to decreasing the number of growing preantral follicles, we found that MIS treatment uncoupled the maturation of germ cells and granulosa cells. In conclusion, MIS suppressed neonatal follicle development by inhibiting proliferation, imposing a quiescent cell state, and preventing granulosa cell differentiation.

Indexed as

AnimalsAnimals, NewbornAnti-Mullerian HormoneCell DifferentiationFemaleInhibinsMiceMice, Inbred C57BLOvarian FollicleOvaryRatsRats, Sprague-DawleyReceptors, PeptideReceptors, Transforming Growth Factor betaSequence Analysis, RNASingle-Cell AnalysisAnti-Mullerian Hormoneanti-Mullerian hormone receptorinhibin-alpha subunitInhibinsReceptors, PeptideReceptors, Transforming Growth Factor betagranulosa cellsMüllerian inhibiting substanceovarian reserveovaryscRNA-seq

Identifiers

PMID33980714
PMCPMC8157966
OpenAlexW3160984047

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.